INBIOGEN Co., Ltd. (KRX:101140)

INBIOGEN Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	88,765	104,740	93,258	93,320	51,597	186,337
Market Cap Growth	21.61%	12.31%	-0.07%	80.86%	-72.31%	-26.46%
Enterprise Value	89,031	104,457	89,287	87,747	118,105	125,455
Last Close Price	8890.00	10490.00	9340.00	9340.00	15500.00	71200.00
PE Ratio	-	-	5.78	8.23	-	1.98
PS Ratio	14.10	16.63	13.25	14.95	4.95	17.78
PB Ratio	0.56	0.66	0.58	0.65	0.37	0.82
P/TBV Ratio	0.56	0.66	0.58	0.66	0.49	1.05
EV/Sales Ratio	14.14	16.59	12.68	14.06	11.34	11.97
Debt / Equity Ratio	0.01	0.01	0.01	0.00	0.01	0.06
Net Debt / Equity Ratio	0.00	0.00	-0.03	-0.04	-0.05	-0.04
Net Debt / EBITDA Ratio	-0.07	-0.07	0.96	1.11	1.66	1.39
Net Debt / FCF Ratio	-0.05	-0.05	41.07	5.10	0.65	1.03
Asset Turnover	0.04	0.04	0.05	0.04	0.05	0.06
Inventory Turnover	94.79	94.79	12.99	4.10	5.61	6.94
Quick Ratio	2.79	2.79	4.32	4.90	3.92	1.07
Current Ratio	2.86	2.86	4.38	5.36	4.39	1.15
Return on Equity (ROE)	-0.89%	-0.89%	10.64%	8.39%	-63.67%	61.55%
Return on Assets (ROA)	-1.68%	-1.68%	-2.47%	-2.66%	-1.78%	-2.74%
Return on Invested Capital (ROIC)	-2.64%	-2.77%	-4.16%	-4.57%	-3.41%	-6.22%
Return on Capital Employed (ROCE)	-2.70%	-2.70%	-3.80%	-4.30%	-4.20%	-3.30%
Earnings Yield	-1.60%	-1.35%	17.29%	12.16%	-227.18%	50.51%
FCF Yield	-6.30%	-5.34%	-0.13%	-1.15%	-22.55%	-5.06%
Buyback Yield / Dilution	-	-	-17.33%	-134.70%	-21.34%	-44.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.